阿麦斯控股有限公司美股招股说明书(2025-11-21版)

This filing under Rule 424(b)(8) is being made to correct the registration number referenced in the previously filed ProspectusSupplement submitted under Rule 424(b)(5) and filed on October 15, 2025, which was filed under an incorrect registration numberdue to a filing error.This filing does not amend, modify or alter the previous filing in any other respect. Filed Pursuant to Rule 424(b)(8)Registration No. 333-289876 PROSPECTUS SUPPLEMENT(To Prospectus Dated September 22, 2025) Up to $6,959,000 Common Stock We have entered into an at-the-market offering agreement dated as of October 15, 2025, or the sales agreement, withLadenburg Thalmann & Co. Inc., or Ladenburg, relating to shares of our common stock, par value $0.001 per share,offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the salesagreement, we may from time to time offer and sell shares of our common stock having an aggregate offering price of upto $6,959,000 through Ladenburg, acting as sales agent. Sales of our common stock, if any, under this prospectus supplement and the accompanying prospectus will be made insales deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933,as amended, or the Securities Act. Ladenburg is not required to sell any specific amount of securities, but will act as oursales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutuallyagreed terms between Ladenburg and us. There is no arrangement for funds to be received in any escrow, trust or similararrangement. Our common stock is listed on the NYSE American under the symbol “AMZE.” On October 14, 2025, the last reportedsale price of our common stock on the NYSE American was $1.96 per share. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell shares pursuant to this prospectus supplementwith a value of more than one-third of the aggregate market value of our common stock held by non-affiliates in any 12-month period, so long as the aggregate market value of our common stock held by non-affiliates is less than $75,000,000.As of October 14, 2025, the aggregate market value of our outstanding common stock held by non-affiliates, or the publicfloat, was $20,877,906, which was calculated based on 6,051,567 shares of our outstanding common stock held by non-affiliates and a closing price of $3.450 per share on September 22, 2025, a date that is within 60 days of filing thisprospectus supplement. As of the date hereof, we have not offered any securities pursuant to General Instruction I.B.6 ofForm S-3 during the prior 12 calendar month period that ends on and includes the date hereof. As a result of theselimitations and the current public float of our common stock, and in accordance with the terms of the sales agreement, wemay offer and sell shares of our common stock having an aggregate offering price of up to $6,959,000 from time to timethrough Ladenburg. Ladenburg will be entitled to compensation at a commission rate of up to 3.0% of the gross proceeds of any shares ofcommon stock sold under the sales agreement. In connection with sales of our common stock on our behalf, Ladenburgwill be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of Ladenburg willbe deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contributionto Ladenburg with respect to certain liabilities, including liabilities under the Securities Act or the Securities Exchange Actof 1934, as amended, or the Exchange Act. Investing in our common stock involves a high degree of risk. See “Risk Factors” beginning on page S-5 of thisprospectus supplement and elsewhere in this prospectus supplement, the accompanying base prospectus and theother documents that are incorporated by reference in this prospectus supplement and the accompanyingprospectus. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapprovedof these securities or determined if this prospectus supplement or the accompanying prospectus is truthful orcomplete. Any representation to the contrary is a criminal offense. Ladenburg Thalmann The date of this prospectus supplement is October 15, 2025. TABLE OF CONTENTS Prospectus Supplement ABOUT THIS PROSPECTUS SUPPLEMENTS-iiPROSPECTUS SUPPLEMENT SUMMARYS-1THE OFFERINGS-3RISK FACTORSS-5SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTSS-7DILUTIONS-8USE OF PROCEEDSS-10PLAN OF DISTRIBUTIONS-11LEGAL MATTERSS-12EXPERTSS-13WHERE YOU CAN FIND ADDITIONAL INFORMATIONS-14INFORMATION INCORPORATED BY REFERENCES-15 Prospectus ABOUT THIS PROSPECTUSiiPROSPECTUS SUMMARY1RISK FACTORS3SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS4USE OF PROCEEDS5DESCRIPTION OF CAPITAL STOCK6DESCRIPTION OF DEBT SECURITIES11DESCRIPTION OF WARRANTS17DESCRIPTION OF SUBSCRIPTION RIGHTS18DESCRIPTION OF